Skip to main content
. 2022 Oct 19;13:1027627. doi: 10.3389/fphar.2022.1027627

FIGURE 2.

FIGURE 2

Mean PK and PD data following administration of multiple doses of SHR2285 for 6 days (A) Time course of mean SHR2285 concentrations; (B) Time course of mean SHR164471 (metabolite of SHR2285) concentrations (C) Time course of mean ratio-to-baseline values for FXIa:C; (D) Time course of mean ratio-to-baseline values for APTT. APTT, activated partial thromboplastin time; FXIa:C, factor XIa coagulation activity; PD, pharmacodynamics; PK, pharmacokinetics.